- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04415970
Understanding Physiology During Float-REST and the Consequential Effects on Subjective and Objective Recovery
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Flotation therapy uses sensory deprivation tanks that consist of a very large warm water enclosure with a high concentration of Epsom salts to create a completely buoyant environment. This, along with a combination of temperature that is kept equal to skin temperature (94 degrees), allows the subject to eliminate the gravitational effects on the body, and along with lack of sound and low to no light (depending on comfort) allows the brain and body to completely relax for augmented physical and mental recovery. To control for potential changes in sleep quality, quantity, and/or stress and anxiety, a control condition utilizing a Metronap nap station to ascertain the effects of standard, horizontal napping with partial sensory deprivation (no light and silence) compared with floating.
To assess whether or not flotation therapy positively influences sleep and perceptual recovery, participants will float for 60 minutes 2 times a week for 8 weeks, use the sleep pod for 60 minutes 2 times a week for 8 weeks, or take part in a cross-over study where the participant will alternate float and sleep pod every 2 weeks for 8 weeks. All participants may wear a fitness tracker and a sleep monitoring ring worn on the finger for the duration of the study. In addition, daily, per session, monthly, and pre/post-study questionnaires will be submitted via a smartphone application.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Joshua Hagan, PhD
- Phone Number: 304-293-4816
- Email: joshua.hagen@hsc.wvu.edu
Study Locations
-
-
West Virginia
-
Morgantown, West Virginia, United States, 26505
- Rockefeller Neuroscience Institute at West Virginia University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Male or female 18 years of age or older
Exclusion Criteria:
- Do not have any contagious skin infections or diseases
- Do not have a history of seizures
- Do not have a history of being prone to motion sickness
- An episode of loss of consciousness (last 6-months)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Flotation Therapy
Participants will utilize flotation sensory deprivation tanks.
|
Participants will float for 60 minutes, 2 times a week for 8 consecutive weeks or alternate with sleep pod every 2 weeks for 8 weeks.
All participants will wear a fitness tracker and a sleep monitoring ring worn on the finger for the duration of the study.
Each session will be preceded by a short safety questionnaire and an anxiety index.
Following each session, the participant will complete the index again.
Participants will also complete morning and evening questionnaires and monthly questionnaires on a smartphone.
|
Active Comparator: Sleep Pod
Participants will utilize sleep pods with partial sensory deprivation (no light and silence).
|
Participants will utilize the sleep pod for 60 minutes, 2 times a week for 8 consecutive weeks or alternate with float every 2 weeks for 8 weeks.
All participants will wear a fitness tracker and a sleep monitoring ring worn on the finger for the duration of the study.
Each session will be preceded by a short anxiety index.
Following each session, the participant will complete the index again.
Participants will also complete morning and evening questionnaires and monthly questionnaires on a smartphone.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in sleep patterns
Time Frame: Daily from baseline through study completion at 8 weeks
|
The OURA Rings is a commercially available wearable device that continuously monitors sleep and sleep quality.
|
Daily from baseline through study completion at 8 weeks
|
Change in self-report measures
Time Frame: Daily from baseline through study completion at 8 weeks
|
Short Recovery and Stress Scale (SRSS)-An 8 item inventory that assess subjective measures of physical, mental, and emotional recovery on a 7 point Likert Scale (0=does not apply at all to 6=fully applies). High values in overall recovery indicate feeling physically and mentally recovered. High values in overall stress indicate feeling overloaded and physically tired. End of Day Questionnaire (EoD)-Developed at the Rockefeller Neuroscience Institute (RNI) as a modification of the NASA Task Load Index. This questionnaire addresses subjective measures of workload and stressors that were encountered throughout the day. Post-Training Rating of Perceived Exertion Questionnaire-An adaption of the Borg Rating of Perceived Exertion scale, commonly referred to as RPE. The questionnaire requires participants to list the specific activity and the subjective measure of exercise intensity. The scale ranges from 6-20 (6=no exertion that is equivalent to rest and 20=maximal exertion). |
Daily from baseline through study completion at 8 weeks
|
Change from baseline in self-report measures
Time Frame: At baseline, at 8 weeks
|
Big Five Inventory (BFI)-44 item inventory designed to measure the Big Five Factors of personality on a 5-point Likert Scale. Higher scores indicate a higher tendency for that personality trait (1=disagree strongly to 5=agree strongly). Emotion Regulation Questionnaire (ERQ)-10-item scale designed to measure tendency to regulate emotions. Each item is answered on a 7-point Likert Scale (1=strongly disagree to 7=strongly agree). Higher scores indicate a higher emotion regulation strategy. Five Facet Mindfulness Questionnaire (FFMQ)-39 item inventory assesses the five facets of mindfulness on a 5-point Likert Scale (1=never or very rarely true and 5=very often or always true). Each facet is tallied and the sum total responses are divided by 39 (number of items). Higher scores indicate higher levels of mindfulness. State-Trait Anxiety Index (STAI)-20 item inventory assesses state and trait anxiety. Values range from 20 to 80, with higher scores representing more severe anxiety. |
At baseline, at 8 weeks
|
Change in monthly self-report measures
Time Frame: At baseline, at 4 weeks, at 8 weeks
|
Acute Recovery and Stress Scale (ARSS)- A 32 item inventory that assess subjective measures of physical, mental, and emotional recovery on a 7 point Likert Scale (0=does not apply at all to 6=fully applies). High values in overall recovery indicate feeling physically and mentally recovered. High values in overall stress indicate feeling overloaded and physically tired. Pittsburgh Sleep Quality Index (PSQI)- 19 item inventory with 7 subjective components that assess sleep quality over time. Each component is scored from 0 to 3 (0=very good and 3=very bad). The sum of the components is the global score and ranges 0-21 (0=no difficulty and 21=severe difficulties). The higher the global score, the poorer the sleep quality. |
At baseline, at 4 weeks, at 8 weeks
|
Change in per session self-report measures
Time Frame: 2 times a week through study completion at 8 weeks
|
State-Trait Anxiety Index (STAI) - Commonly used measure of state and trait anxiety, and done with 20 very brief questions.
Values range from 20 to 80, with higher scores representing more severe anxiety.
Participants will take the STAI questionnaire before and after each intervention session.
|
2 times a week through study completion at 8 weeks
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1910751767
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Quality
-
PrecisionBiotics Group Ltd.Nottingham Trent University; Atlantia Food Clinical Trials Ltd.CompletedSubjective Sleep Quality | Objective Sleep QualityIreland
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionEnrolling by invitation
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Icahn School of Medicine at Mount SinaiNot yet recruiting
-
West Virginia UniversityActive, not recruiting
-
West Virginia UniversityCompletedSleep QualityUnited States
-
Sakarya UniversityEnrolling by invitation
-
Maharishi Markendeswar University (Deemed to be...Completed
-
Osmaniye Korkut Ata UniversityNot yet recruiting
Clinical Trials on Flotation therapy sensory deprivation tank
-
Amrinder BabbraTerminated
-
West Virginia UniversityEnrolling by invitation
-
Neurological Surgery, P.C.UnknownGliosarcoma | GlioblastomasUnited States
-
Medical University of South CarolinaCompletedBipolar Depression | Non-Psychotic Unipolar DepressionUnited States
-
State University of New York College of OptometryNational Eye Institute (NEI); Nova Southeastern University; University of Maryland...Unknown
-
West Virginia UniversityActive, not recruitingSleep QualityUnited States
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
Chinese University of Hong KongActive, not recruitingProstate CancerHong Kong
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Active, not recruiting
-
Northwestern UniversityNational Cancer Institute (NCI)RecruitingMetastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate CarcinomaUnited States